Clinical assessment of ChAdOx1 vectored vaccines against emerging pathogens

Clinical assessment of ChAdOx1 vectored vaccines against emerging pathogens

<p>Traditional vaccine development strategies are costly and time-consuming which makes them unsuitable for clinical assessment of new vaccines in the context of infectious diseases outbreaks. Platform technologies provide substantial manufacturing advantages and have the potential to signific...

書誌詳細
第一著者:	Moreira Folegatti, P
その他の著者:	Gilbert, S
フォーマット:	学位論文
言語:	English
出版事項:	2021
主題:	Vaccine Clinical Development

類似資料

Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
著者:: Adam Berg, 等
出版事項: (2021-10-01)

Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV
著者:: Charlotte Davis, 等
出版事項: (2024-06-01)

Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
著者:: Zhang, C, 等
出版事項: (2023)

Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
著者:: Cheng Zhang, 等
出版事項: (2023-06-01)

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
著者:: Natalie Gabrielle Marchevsky, 等
出版事項: (2022-07-01)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
著者:: Pedro M. Folegatti, 等
出版事項: (2019-05-01)

CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination
著者:: Hannah R. Sharpe, 等
出版事項: (2022-03-01)

Thromboses of major arteries and ChAdOx1 nCov-19 vaccination
著者:: Rujittika Mungmunpuntipantip, 等
出版事項: (2021-11-01)

Impact of Improper Storage of ChAdOx1-S (AstraZeneca) Vaccine on Its Efficacy and Safety
著者:: Marek Mikołajczyk, 等
出版事項: (2022-12-01)

Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines
著者:: César López-Camacho, 等
出版事項: (2020-06-01)

Population-wide persistent hemostatic changes after vaccination with ChAdOx1-S
著者:: Bas de Laat, 等
出版事項: (2022-07-01)

ChAdOx1 vaccination, blood coagulation, and inflammation: No effect on coagulation but increased interleukin‐6
著者:: Loes H. Willems, 等
出版事項: (2021-12-01)

Effectiveness of the chAdOx1 nCoV-19 vaccine in preventing COVID-19 infection
著者:: Tarana Sarwat, 等
出版事項: (2022-01-01)

Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 Vaccine in Saudi Arabia
著者:: Salma Al Bahrani, 等
出版事項: (2021-09-01)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
著者:: Folegatti, P, 等
出版事項: (2019)

A rare case of bilateral optic neuritis post-Covishield (ChAdOx1-S [recombinant]) vaccination
著者:: Tanie Natung, 等
出版事項: (2023-01-01)

Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination
著者:: Simone Barocci, 等
出版事項: (2022-03-01)

Neutralizing Antibody and T-Cell Responses against SARS-CoV-2 Wild-Type and Variants of Concern in Chronic Obstructive Pulmonary Disease Subjects after ChAdOx-1/ChAdOx-1 Homologous Vaccination: A Preliminary Study
著者:: Warawut Chaiwong, 等
出版事項: (2022-12-01)

Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine
著者:: Lea Krutzke, 等
出版事項: (2022-07-01)

IgA Vasculitis Following ChAdOx1 nCoV-19 Vaccination
著者:: Manabendra Basu, 等
出版事項: (2024-01-01)

LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination
著者:: Tamara Garibashvili, 等
出版事項: (2022-06-01)

Heterologous vaccination (ChAdOx1 and BNT162b2) induces a better immune response against the omicron variant than homologous vaccination
著者:: Jaeeun Yoo, 等
出版事項: (2023-10-01)

Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine
著者:: Edmund G.-T. Wee, 等
出版事項: (2024-08-01)

Vaccine‐induced immune thrombotic thrombocytopenia with ChAdOx1 nCoV‐19 is rare in Asia
著者:: Kochawan Boonyawat, 等
出版事項: (2022-01-01)

DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination
著者:: Gerardo Casucci, 等
出版事項: (2021-06-01)

ChAdOx1 nCoV-19 Vaccine Side Effects among Healthcare Workers in Trinidad and Tobago
著者:: Chavin D. Gopaul, 等
出版事項: (2022-03-01)

Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination – A Case Report
著者:: Martin Koch, 等
出版事項: (2021-07-01)

Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
著者:: Larissa Henze, 等
出版事項: (2023-01-01)

Sarcoidosis presenting as bilateral optic neuritis after ChAdOx1 nCoV-19 vaccination
著者:: Amarendra Kumar Shukla, 等
出版事項: (2022-06-01)

Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination
著者:: Wang-Huei Sheng, 等
出版事項: (2022-04-01)

Association of Reactogenicity with Immunogenicity of the ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Hemodialysis
著者:: Ting-Yun Lin, 等
出版事項: (2022-08-01)

AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy
著者:: Syed B. Ali, 等
出版事項: (2022-03-01)

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
著者:: Hermosilla, E, 等
出版事項: (2022)

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
著者:: Eduardo Hermosilla, 等
出版事項: (2022-03-01)

Antibody Detection in Healthcare Workers after Vaccination with Two Doses of the BNT162b2 or ChAdOx1 Vaccine
著者:: Kyoung Ho Roh, 等
出版事項: (2022-09-01)

Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
著者:: Jer-Hwa Chang, 等
出版事項: (2022-02-01)

Immunogenicity Differences of the ChAdOx1 nCoV-19 Vaccine According to Pre-Existing Adenovirus Immunity
著者:: Jinnam Kim, 等
出版事項: (2023-04-01)

Adult-onset Still's disease after ChAdOx1 nCoV-19 vaccine: a possible association
著者:: Laíssa Fiorotti Albertino, 等
出版事項: (2022-11-01)

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV
著者:: Tamsin Cargill, 等
出版事項: (2023-11-01)

New Onset of Giant Cell Arteritis following ChAdOx1-S (Vaxevria<sup>®</sup>) Vaccine Administration
著者:: Luca Lo Sardo, 等
出版事項: (2023-02-01)